Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Byrne

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
The Oncologist|February 28, 2019
Predictors of Success of Phase II Pediatric Oncology Clinical TrialsLaura Franshaw, Maria Tsoli, Jennifer Byrne, et al.
The Journal of Biological Chemistry|December 26, 2001
The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activityEleanor Y M Sum, Benjamin Peng, Xin Yu, et al.
Nature|January 27, 2025
'Stamp out paper mills' - science sleuths on how to fight fake researchAnna Abalkina, René Aquarius, Elisabeth Bik, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 28, 2010
Evaluation of Zinc-α-2-Glycoprotein and Proteasome Subunit β-Type 6 Expression in Prostate Cancer Using Tissue Microarray TechnologyGillian O'Hurley, Anthony O'Grady, Paul Smyth, et al.
Leukemia Research|May 3, 2014
Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphomaVictor Noriega, Harpreet Kaur, Stephen Devereux, et al.
Biopreservation and Biobanking|November 18, 2017
Is Your Biobank Up to Standards? A Review of the National Canadian Tissue Repository Network Required Operational Practice Standards and the Controlled Documents of a Certified BiobankVictoria Hartman, Tania Castillo-Pelayo, Sindy Babinszky, et al.
The Lancet. Haematology|June 16, 2019
De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trialRichard E Clark, Fotios Polydoros, Jane F Apperley, et al.
British Journal of Haematology|November 19, 2016
The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF)Ruben Mesa, Alessandro M Vannucchi, Abdulraheem Yacoub, et al.
Nature Medicine|January 12, 2021
Automated screening of COVID-19 preprints: can we help authors to improve transparency and reproducibility?Tracey Weissgerber, Nico Riedel, Halil Kilicoglu, et al.
Leukemia|September 17, 2024
Correction: Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registryEkaterina Chelysheva, Jane Apperley, Anna Turkina, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The Oncologist|February 28, 2019
Predictors of Success of Phase II Pediatric Oncology Clinical TrialsLaura Franshaw, Maria Tsoli, Jennifer Byrne, et al.
The Journal of Biological Chemistry|December 26, 2001
The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activityEleanor Y M Sum, Benjamin Peng, Xin Yu, et al.
Nature|January 27, 2025
'Stamp out paper mills' - science sleuths on how to fight fake researchAnna Abalkina, René Aquarius, Elisabeth Bik, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 28, 2010
Evaluation of Zinc-α-2-Glycoprotein and Proteasome Subunit β-Type 6 Expression in Prostate Cancer Using Tissue Microarray TechnologyGillian O'Hurley, Anthony O'Grady, Paul Smyth, et al.
Leukemia Research|May 3, 2014
Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphomaVictor Noriega, Harpreet Kaur, Stephen Devereux, et al.
Biopreservation and Biobanking|November 18, 2017
Is Your Biobank Up to Standards? A Review of the National Canadian Tissue Repository Network Required Operational Practice Standards and the Controlled Documents of a Certified BiobankVictoria Hartman, Tania Castillo-Pelayo, Sindy Babinszky, et al.
The Lancet. Haematology|June 16, 2019
De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trialRichard E Clark, Fotios Polydoros, Jane F Apperley, et al.
British Journal of Haematology|November 19, 2016
The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF)Ruben Mesa, Alessandro M Vannucchi, Abdulraheem Yacoub, et al.
Nature Medicine|January 12, 2021
Automated screening of COVID-19 preprints: can we help authors to improve transparency and reproducibility?Tracey Weissgerber, Nico Riedel, Halil Kilicoglu, et al.
Leukemia|September 17, 2024
Correction: Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registryEkaterina Chelysheva, Jane Apperley, Anna Turkina, et al.
Pageof 5